Follow Tom On:
Categories
-
Recent Posts
- Linking To And Excerpting From Nature Communications’ “Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases”
- Linking To And Embedding International Autoimmune Encephalitis Society’s “Pediatric Autoimmune Encephalitis with Dr. Mellad Khoshnood | Causes, Symptoms & Diagnosis | IAES” With A Link To “A clinical approach to diagnosis of autoimmune encephalitis”
- Linking To And Embedding MD Newsline’s “What Doctors Still Don’t Know About Autoimmune Encephalitis ft. Dr. Stacey Clardy” With A Link To “A Clinical Approach To Diagnosis Of Autoimmune Encephalitis
- Linking To And Embedding The Center For Medical Education’s “Resuscitative C-Section | Incrementum On-Demand”
- Linking To And Embedding The Center for Medical Education’s “Simulation – Cric or Die | Incrementum On-Demand”
- Linking To And Excerpting From The Coalition For Metabolic Health’s “Policy Brief: GLP-1 Medications”
- Linking To And Embedding Metabolic Mind’s “Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health”
- Google Search: “Validated Large Vessel Occlusion Assessment Tools”
- Does Central Indiana Have Mobile Stroke Unit Services? Yes!
- Linking To And Embedding Metabolic Mind’s “Exercise as a Prescription for Depression with Dr. Nicholas Fabiano”
- Linking To And Excerpting From Metabolic Mind’s “Can Creatine Help with Depression? Exploring the Science with Dr. Nick Fabiano”
- Linking To And Excerpting From “2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association” With Links To Four Video Summaries From EM Note
- Reviewing Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD Deficiency) From StatPearls
- Reviewing Methemoglobinemia From StatPearls
- Linking To And Excerpting From EMC’s “BCE 80 Pediatric Respiratory Failure”
- Linking To And Excerpting From EMC’s “BCE 82 Perimortem C-section – The Resuscitative Hysterotomy”
- Linking To And Embedding EM Note’s “Pitfalls in Metabolic Acidosis Management” With A Link To An Additional Resource
- Google Search: What Is A Hazard Ratio?
- Google Search: “How Do You Diagnose G6PD (Glucose-6-Phosphate Dehydrogenase) Deficiency”
- Linking To And Embedding Metabolic Mind’s ” Can Keto Transform Type 1 Diabetes Treatment? A Decade of Insights from Dr. Andrew Koutnik”
- Linking To And Embedding Metabolic Mind and Dr. Andrew Koutnik, PhD’s “NEW Research Challenges Everything We Know About Carbs & Exercise”
- Linking To And Embedding EM Note’d “SMA Occlusion”
- Linking To The American Psychiatric Association’s Book “Quick Structured Clinical Interview for DSM-5® Disorders (QuickSCID-5)”
- Linking To “DSM-5-TR Online Assessment Measures”
- Linking To And Embedding EM Note’s “Vasopressors and Inotropes for Shock Management”
- Linking To And Embedding Dementia Care Aware’s “ADL / IADL Checklist”
- Linking To And Excerpting From American Journal Of Neuroradiology’s “Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist”
- Linking To And Excerpting From Biomolecules & Biomedicine’s “The role of magnetic resonance imaging in the diagnosis and prognosis of dementia”
- The Business Of Healthcare: Linking To “Weight Medicine with Dr. Meghan MD”
- Linking To And Embedding EM Note’s “COPD Management Pitfalls”
Category Archives: Nature Communications
Linking To And Excerpting From Nature Communications’ “Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases”
Today, I review, link to, and excerpt from Nature Communications‘ “Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases“. [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. Nat Commun. 2026 Jan 7;17(1):972. doi: 10.1038/s41467-025-67701-9. There are … Continue reading
Posted in GLP-1 Agonist Side Effects, GLP-1 Agonists, GLP-1 Receptor Agonists, Nature Communications
Comments Off on Linking To And Excerpting From Nature Communications’ “Comprehensive evaluation of GLP-1 receptor agonists: an umbrella review of clinical outcomes across multiple diseases”